19May
19May
Aircuity announces new vice president of operations
Aircuity in Newton announced that Tom Nasti joined the company as the vice president of operations. Read more >>
15May
Cruising along: 5 tech firms that are thriving in the pandemic
Wasabi on list. Read more >>
15May
Collaborating on Rare Disease R&D
This week on Growing Greater we learn of rare and serious systemic autoimmune condition known as dermatomyositis. We learn of Corbus Pharmaceuticals’ collaboration with University of Pennsylvania on a Phase 2 study, which has shown positive results. Read more >>
14May
CytoAgents Receives NIH Funding to Accelerate Treatment for Cytokine Storm
CytoAgents awarded $1.6 million National Institutes of Health (NIH) grant to accelerate treatment for cytokine storm. Read more >>
13May
Premama Wellness raises $3.5M in first institutional funding round
Premama Wellness, a Providence-based startup that sells supplements for maternity wellness, has attracted its first institutional investor since launching in 2011: District Ventures Capital, a Canadian venture capital fund hyper-focused on the food, beverage and health and wellness sectors. Read more >>
08May
Emovi Selected by the Consulate General of Canada in Boston, to Join the 2020 Cohort for the Canadian Technology Accelerator
Emovi, Inc., a Canadian medical device company, announced today that they were selected to join the Canadian Technology Accelerator (CTA) in Boston, MA. Emovi was selected with 10 other companies to participate in the 2020 cohort. Read more >>
06May
Hoth Therapeutics Expands Partnership with Zylö Therapeutics, Inc.
Hoth Therapeutics, Inc., a biopharmaceutical company, today announced it has completed a strategic investment in Zylö Therapeutics, Inc. Mr. Robb Knie, Chief Executive Officer of Hoth, commented, "We are pleased to expand our partnership with Zylö and look forward to working together as our therapeutic for Lupus patients continues through the next phase of development. Read more >>
06May
LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures
LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) from the National Institute of Neurological Disorders and Stroke to advance the development of Tetranite®, its bone adhesive biomaterial technology, to improve cranial flap fixation procedures. Read more >>
06May